AstraZeneca Pharma shares likely to break 4-day losing streak on approval for cancer drug
Market capitalisation stands at Rs 19,771.25 crore. The share touched a 52-week high of Rs 9,049.95 and a 52-week low of Rs 5 ...
Targeted Oncology15h
The Targeted Pulse: New Approvals Are Advancing the Field, and the MARIPOSA Trial Continues to Deliver
The FDA approved agents in MIBC and neuroendocrine tumors and amivantamab/lazertinib continues to shine in NSCLC.